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Abstract 
Background: Obesity is considered a major health concern and mounting evidence suggests that the exposure 
to environmental endocrine disruptors, including Bisphenol-A (BPA), may enhance the risk to develop the disease. 
Moreover, growing documents propose that the vitamin D may contribute to adipogenic signaling and lipid accu-
mulation during adipocyte differentiation. We focused on the molecular mechanism of vitamin D and BPA in human 
adipose-derived mesenchymal stem cells (hADMSCs) which vitamin D and BPA may influence adipose tissue develop-
ment and function.
Methods: Human adipose-derived mesenchymal stem cells were cultured for 14 days in lipogenic differentiation 
media containing continuous concentrations of vitamin D plus BPA (0.1 nM or 10 nM). The expression of adipogenic 
markers including the peroxisome proliferator-activated receptor γ (PPARγ), CCAAT-enhancer-binding protein α (C/EBP 
α) CCAAT-enhancer-binding protein β (C/EBP β), fatty acid synthase (FASN), lipoprotein lipase (LPL), sterol regulatory 
element-binding protein-1c (SREBP1c), insulin-induced gene-2 (INSIG2), vitamin D receptor (VDR), estrogen receptor-
beta (ER-β), fatty acid-binding protein-4 (FABP4), and glucose transporter-4 (GLUT4) was measured using Quantitative 
polymerase chain reaction (qPCR) and enzyme-linked immunosorbent assay (ELISA). Lipid accumulation was visual-
ized with staining with Oil Red O.
Results: In the morphological assessment of mesenchymal stem cells treated with a concentration of 10 nM vitamin 
D plus BPA, more lipid accumulations were observed in comparison with the group with 0.1 nM concentration. Treat-
ment of hADMSCs with vitamin D plus BPA (0.1 nM) significantly inhibited the induction of PPARγ, C/EBP β, C/EBP α, 
and FASN related to adipocyte differentiation and development. However, the exposure of cells to the concentration 
of 10 nM vitamin D plus BPA induced the expression of these genes associated to the adipogenesis. The remarkable 
increase in the level of SREBP1c was associated to the suppression of INSIG2 in treated preadipocytes with 10 nM vita-
min D plus BPA. Our findings showed that the expression of VDR, ERβ, GLUT4, and FABP4 were upregulated through 
differentiation with the highest concentrations in 0.1 nM vitamin D plus BPA group for VDR, ERβ, and GLUT4.
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Background
Obesity is a chronic disease in which the excess adipose 
tissue has accumulated in the body. Fat accumulation is 
considerably related to cardiovascular disease, diabe-
tes type 2, hypertension, sleep apnea, musculoskeletal 
disorders, psychological conditions, and a few cancers. 
Moreover, obesity is contributed to higher mortality and 
morbidity rates as well as reduced life expectancy [1, 2].
The regulation of adipose tissue expansion is a remark-
able process characterized by the increase in the volume 
of adipocytes known as hypertrophy and the number of 
adipocytes known as hyperplasia called adipogenesis. 
These are necessary for lipid storage and development to 
form the mature adipocytes [3–5].
The expression of nuclear and membrane vitamin D 
receptors (VDR) in adipocytes proposes that adipose tis-
sue is responsive to vitamin D. A range of mechanisms by 
which vitamin D possibly affects adipogenesis and energy 
balance were suggested [6, 7].
The evidence supports stimulating and suppressing 
actions of vitamin D on adipogenesis. In mouse mod-
els, vitamin D blunted adipogenesis through acting on 
various targets suppressing the expression of CCAAT-
enhancer-binding protein α  (C/EBPα) and peroxisome 
proliferator-activated receptor γ (PPARγ), downregulat-
ing the mRNA expression of CCAAT-enhancer-binding 
protein β (C/EBP β) and its nuclear protein levels in 
3T3-L1 preadipocytes [8, 9]. In 3T3-L1 preadipocytes, 
vitamin D inhibits the adipogenesis by suppressing C/
EBPα and PPARγ expression and down-regulating tran-
scription of C/EBPβ and its nuclear protein. Vitamin D 
also activates Eight-Twenty-One factor (ETO), C/EBPβ 
co-receptor, which plays more inhibitory role on the C/
EBPβ function. WNT/β-Catenin keeps preadipocyte cells 
in the undifferentiated phase which prevents adipogen-
esis. Vitamin D exerts the anti-adipogenic effects on 3T3-
L1 cells by maintaining the expression levels of nuclear 
WNT10B and β-Catenin and suppressing PPARγ [9].
In human tissue, vitamin D stimulates the differentia-
tion of subcutaneous preadipocytes by augmenting the 
expression of fatty acid-binding protein-4 (FABP4), and 
lipoprotein lipase (LPL) [10, 11]. Vitamin D enhances 
lipid accumulation and increases expression of adi-
pogenic genes, including fatty acid synthase (FASN), 
FABP4, and PPARγ to differentiate mesenchymal cells to 
adipocytes [12–14].
The rising prevalence of obesity was preceded by an 
exponential growth to produce synthetic chemicals 
which resulted in proposing a new hypothesis called 
environmental obesogen [15]. Bisphenol A (BPA) is a 
lipophilic compound characterized as an endocrine dis-
rupter with estrogen mimetic activity. BPA is so wide-
spread in the daily human environment which found in 
products including polycarbonate plastics, the lining of 
canned food, beverage, and more. Therefore, it can trans-
fer into human bodies. BPA is detected in human plasma 
and urine as well as in the human milk [15–19]. The 
experimental data report that BPA interferes with main 
weight controlling hormones such as thyroid hormones, 
estrogen, testosterone, glucocorticoids, and leptin. BPA 
acts as a potential disrupter to develop obesity by provok-
ing lipid accumulation and differentiating preadipocytes 
from the mature adipocytes by expressing adipogenic 
genes such as C/EBP α, FABP4, PPARγ, and LPL [17, 20–
22]. BPA in micromole concentrations induces the differ-
entiation of adipocytes, while in nanomol concentrations, 
it reduces insulin sensitivity in adipose tissue. Decreased 
Glucose transporter-1 (GLUT-1) expression and insulin 
receptor phosphorylation impair glucose metabolism and 
increase the risk of diabetes type 2.
BPA interacts with nuclear estrogen receptors, glu-
cocorticoids, PPARγ, retinoid X receptor (RXR), and 
thyroid at nuclear micromol concentrations which is all 
these receptors are involved in adipogenesis [17]. BPA 
induced adipocyte differentiation and lipid accumula-
tion through activating these receptors [17]. We tested 
the effects of vitamin D plus BPA on the differentiation of 
human adipose derived mesenchymal stem cells (hADM-
SCs) to adipocytes.
Methods
Human adipose‑derived stem cells
hADMSCs obtained from the human cell bank of Iranian 
Biological Resource Center laboratory (Tehran, Iran). 
Written informed consent for using and collecting the 
cells and tissues was obtained from all donors. Human 
ASC highly used in all experiments were from subcuta-
neous abdominal adipose tissue of female donors with an 
average age of 37 and body mass index (BMI) average of 
26.2 kg/m2. Dulbecco’s modified Eagle medium (DMEM) 
supplemented with 10% FBS, and 2% glutamine, 100 IU/
ml penicillin, and 100  IU/ml streptomycin were used as 
Conclusions: Vitamin D plus BPA at concentration of 10 nM boosted the adipogenesis during the critical stages of 
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growth media which incubated at 37 °C with 5% humidi-
fied  CO2. The cells were passed when they reached 
80–90% confluence with media changed in the 2–3-day 
interval. Once 80–90% confluence was reached (4 pas-
sage), all wells were divided into three experimental 
groups with at least three parallel wells in each group: 
(i) 0.1 nM of vitamin D plus 0.1 nM of BPA with induc-
tion; (ii) 10 nM of vitamin D in the active metabolic form, 
1,25-dihydroxyvitamin D3, plus 10 nM BPA with induc-
tion; (iii) control with induction and without vitamin D 
or BPA. To induce the differentiation into mature adi-
pocytes, cells were suspended and cultured in an adipo-
cyte differentiation medium (Gibco, UK) involving the 
concentrations of 0.5  mM 3-isobutyl-3-methylxanthine 
(IBMX), 1 mM dexamethasone, 5 mg/ml human insulin 
for 14 days. After a week, the media were replaced with 
an adipocyte maintenance medium (Gibco, UK) and cul-
tured for 7  days. Treatment compounds were added at 
the same concentrations when media was changed. All 
these mix changes were done in parallel in control cells 
without vitamin D. Cells were collected and harvested to 
assess messenger ribonucleic acid (mRNA) adipogenic 
genes at hours 1, 3, and days 1, 3, 7 and 14 during the dif-
ferentiation. All chemical materials were purchased from 
Sigma-Aldrich.
Quantitative real‑time reverse transcription‑PCR (qRT‑PCR)
The mRNA level of adipogenesis-related genes, PPARγ, 
C/EBPα, C/EBPβ, LPL, FASN, sterol regulatory element-
binding protein-1c (SREBP-1c), Insulin-induced gene 
2 (INSIG2) were quantified by qRT-PCR assay. After a 
2-week adipogenic-induction, total RNA was extracted 
from differentiating cells treated using TRIzol reagent 
(Sigma-Aldrich) due to the manufacturer’s instruc-
tion, and then RNA was reverse transcribed into cDNA 
using Superscript II reverse transcriptase kit (Invitro-
gen) following manufacturer’s protocol. Quantitative 
PCR analysis was performed using StepOnePlus PCR 
System (Applied Biosystems) and SYBR Premix Ex Taq 
II, Tli RNaseH Plus (Takara, Japan). Fold changes in 
gene expression level were calculated by  2−∆∆Ct method, 
and the results were normalized to the expression of an 
internal control, Glyceraldehyde-3-Phosphate Dehydro-
genase (GAPDH). PCR primer sequences were listed as 
followed, with primer specificity confirmed on NCBI 
Primer-BLAST website:
PPARγ: Forward 5′-CAG AAA TGC CTT GCA GTG 
GG-3′, Reverse 5′-AAC AGC TTC TCC TTC TCG GC-3′; 
C/EBPα: Forward 5′-TAT AGG CTG GGC TTC CCC TT-3′, 
Reverse 5′-AGC TTT CTG GTG TGA CTC GG-3′; C/EBPβ: 
Forward 5′-TTT GTC CAA ACC AAC CGC AC-3′, Reverse 
5′-GCA TCA ACT TCG AAA CCG GC-3′; SREBP1c: For-
ward 5′-TCT CAG TCC CCT GGT CTC TG-3′, Reverse 
5′-ATA GGC AGC TTC TCC GCA TC-3′; insig-2: Forward 
5′-AGT GGT CCA GTG TAA TGC GG-3′, Reverse 5′-TGG 
ATA GTG CAG CCA GTG TG-3′; LPL: Forward 5′-GCT 
CAG GAG CAT TAC CCA GTGTC, Reverse 5′-GCT CCA 
AGG CTG TAT CCC AAGA-3′; FASN: Forward 5′-ATT 
CTG CCA TAA GCC CTG TC-3′, Reverse 5′-CTG TGT 
ACT CCT TCC CTT CTTG-3; and GAPDH: Forward 
5′-CAT GAG AAG TAT GAC AAC AGCCT-3′, Reverse 
5′-AGT CCT TCC ACG ATA CCA AAGT-3′.
Oil Red O staining
To evaluate the cellular neutral lipid droplet accumu-
lation, mature adipocytes were washed three times 
with iced phosphate-buffered saline (PBS) which fixed 
with 4% paraformaldehyde for 30  min. After fixation, 
the cells were washed three times and stained with Oil 
Red O solution (ORO) for 15  min at room tempera-
ture. Cells were washed three times again with PBS to 
remove unbound staining. ORO-stained adipocytes were 
observed under a microscope (Olympus, Tokyo, Japan), 
and digital images were captured at 100× magnification.
Protein assay
To determine protein concentration, the plated cells were 
lysed in a buffer involving 50 mM Tris, 150 mM sodium 
chloride (NaCl), 1% IGEPAL, 5  mM EDTA (Sigma-
Aldrich), protease inhibitor cocktail (Roche Diagnostics, 
Laval, QC, Canada), and centrifuged for lysate collec-
tion. Using specific enzyme-linked immunosorbent assay 
(ELISA) kits (Human FABP4 ELISA kit, Human GLUT4 
ELISA kit, Human ERβ ELISA kit, purchased from Zell-
Bio GmbH, Ulm, Germany), and a microplate reader 
(Epoch Model, BioTek, Vermont, USA). The intra assays 
precision by the coefficient of variation percent (CV %) 
related to each ELISA kit were 5.5, 5.8, 6.1, and 5.9 per-
cent, respectively.
Statistics
Data are expressed as means ± standard deviation (SD). 
The mRNA expressions were determined by analysis of 
variance (ANOVA) with repeated measures and 2-tailed 
Student t-tests (SPSS 25 for Windows, standard version; 
SPSS Inc., Chicago, IL, USA).Using GraphPad (GraphPad 
Software) and the protein expressions were determined 
by Kruskal–Wallis one-way analysis of variance and 
Dunn’s multiple comparison test. Means were considered 
statistically different when p values were less than 0.05.
Results
The morphology of human adipose-derived mesenchy-
mal stem cells and lipid accumulation were indicated 
during the differentiation (Fig. 1). More lipid accumula-
tions were observed in control and mesenchymal stem 
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cells treated by 10 nM concentrations of vitamin D plus 
BPA compared to 0.1 nM vitamin D plus BPA.
To determine vitamin D plus BPA induced effects on 
adipogenesis, the mRNA expression of key adipogenic 
markers and transcription factors were evaluated using 
qPCR. Vitamin D plus BPA (10  nM) enhanced expres-
sion of PPARγ mRNA (P = 0.028) in the early phase of 
this experiment. In contrast, mRNA expression of PPARγ 
was suppressed (P = 0.022) through differentiation in 
response to 0.1 nM vitamin D plus BPA (Fig. 2a).
To evaluate whether vitamin D plus BPA affect early 
or late adipogenesis events, we next assessed the time 
course effects on mRNA levels of key transcription fac-
tors during differentiation. C/EBPα expression was sig-
nificantly increased at 6 days post-treatment in response 
to 10 nM vitamin D plus BPA (P = 0.01), the treatment of 
cells with 0.1 nM vitamin D plus BPA resulted in a statis-
tically significant reduction (P = 0.006) in the mRNA lev-
els of C/EBPα during differentiation (Fig. 2b). While, the 
mRNA expression of C/EBPβ, an early adipogenic tran-
scription factor, was inhibited (P < 0.001) with vitamin 
D plus BPA (0.1 nM), a statistically significant enhanced 
expression was observed on day 6 (P = 0.004) in the 
treated cells with vitamin D plus BPA (10 nM) (Fig. 2c).
The levels of FASN mRNA, a marker of de novo lipo-
genesis, were significantly augmented on day 6 from the 
beginning of the differentiation process of adipogenesis 
in cells treated by 10 nM vitamin D plus BPA (P = 0.003); 
however a reduction was markedly observed (P = 0.03) 
in 0.1  nM vitamin D plus BPA group (Fig.  3a). Vitamin 
D plus BPA (0.1 nM) treatment resulted in a suppression 
of LPL mRNA expression (a late marker of adipogenesis) 
at day 3 (P = 0.01). While the expression of LPL mRNA 
had the fluctuation with an increase (P = 0.02) during the 
early period of differentiation (day 3) (Fig. 3b). Following 
vitamin D plus BPA (10 nM) exposure, mRNA expression 
of SREBP1c was significantly increased (P = 0.005) during 
adipogenesis. Moreover, SREBP1c mRNA levels were sig-
nificantly prohibited upon vitamin D plus BPA (0.1 nM) 
exposure (P = 0.034).
The treatment with 0.1 nM of vitamin D plus BPA sig-
nificantly repressed mRNA levels of INSIG2 (P = 0.005), 
an intermediate regulator between PPARγ and SREBP1c 
(Fig. 4b). However, the expression levels of INSIG2 were 
not significantly affected by 10 nM of vitamin D plus BPA 
(Fig. 4b).
Afterwards, vitamin D effect plus BPA treatment on the 
protein levels of FABP4, other late markers of adipogene-
sis, was assessed. The findings showed that protein levels 
of FABP4 were statistically significant increased in con-
trol and vitamin D plus BPA (10 nM) groups, not in the 
concentration of 0.1  nM vitamin D plus BPA (Table  1). 
Furthermore, the protein level of GLUT4 was gradually 
augmented with higher concentration upon 0.1 nM vita-
min D plus BPA exposure (Table 1).
To address whether VDR or ERβ are involved in the 
action of vitamin D and BPA during human preadi-
pocyte differentiation, protein levels of VDR and ERβ 
were measured. Vitamin D plus BPA dose-dependently 
enhanced VDR and ERβ expression levels compared to 
the control group (Table 1).
Discussion
For the first time and to the best of our knowledge, we 
tested the collective effects of vitamin D and BPA on 
adipogenesis in hADMSCs. Our results provide original 
Fig. 1 Oil Red O staining of human adipose-derived mesenchymal stem cells. Phase contrast image of adipocytes were taken by microscope 
(Olympus, Tokyo, Japan) and digital images were captured at ×100 magnification. Following 14 days of treatment with vitamin D plus BPA showed 
a significant increase in relative lipid vacuole staining compared with control group
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insights into vitamin D and BPA actions on adipogenic 
differentiation of human adipose-derived stem cells. Vita-
min D and BPA was added to the culture before differen-
tiation started to investigate the impact of early exposure 
on undifferentiated cells. We observed that exposure to 
vitamin D plus BPA modulates adipocyte differentiation 
by altering the expression of master adipogenic mark-
ers. The expression of genes associated to adipogenic 
Fig. 2 Vitamin D plus BPA modulates the mRNA expression of adipogenic marker genes during adipogenesis dose-dependently. mRNA expression 
of PPARγ (a), C/EBPα (b) and C/EBPβ (c) in vitamin D plus BPA (10 nM or 0.1 nM) groups during adipogenic differentiation. The relative qPCR values 
were corrected to GAPDH expression levels and normalized with respect to controls on each time. The mRNA levels are expressed as the fold 
increase relative to the control
Fig. 3 Vitamin D plus BPA  (10−8 M) augmented mRNA expression of FASN and LPL in adipocytes. mRNA expression of FASN (a) and LPL (b) in 
vitamin D plus BPA groups during adipogenic differentiation. The relative qPCR values were corrected to GAPDH expression levels and normalized 
with respect to controls on each time. The mRNA levels are expressed as the fold increase relative to the control
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differentiation, including PPARγ, C/EBPα, C/EBPβ, 
FASN, LPL, and SREBP1c, was significantly enhanced 
through treatment with 10  nM vitamin D plus BPA. 
However, the expression of these genes was inhibited in 
cells treated to 0.1 nM vitamin D plus BPA. Besides, the 
expression level of proteins, including VDR, ERβ, and 
FABP4, was augmented. Since many researches have con-
firmed the effect of BPA to induce the adipogenic differ-
entiation [17, 19, 20], this difference in gene expression is 
related to the effect of vitamin D [23, 24]. Moreover, we 
observed inhibited lipid accumulation in mature adipo-
cytes treated with 0.1 nM vitamin D plus BPA.
The evaluation of gene expression in subcutaneous 
adipocytes showed significant inhibition of apoptosis by 
vitamin D. Findings from diet-induced obese mice con-
firmed that increased vitamin D intake due to induced 
apoptosis was negatively correlated to the volume of 
white adipose tissue. Apoptosis was prohibited in 3T3-L1 
differentiated cells in a low dose of vitamin D, although 
apoptosis promoted by the high dose of vitamin D. Vita-
min D in physiological dose suppresses mitochondrial 
uncoupling protein-2 (UCP2), enhanced mitochondrial 
potential and adenosine triphosphate (ATP) production, 
and repressed apoptosis [7]. It is postulated that a steady 
rise in intracellular calcium induced apoptosis by acti-
vating calpain-dependent calcium protease followed by 
activating caspase-12. In mature adipocytes, vitamin D 
stimulated voltage-dependent and non-voltage-depend-
ent  Ca2+ fluxes through Inositol 1,4,5-trisphosphate 
receptor/Ca2+ release channels (IP3R) and Ryanodine 
receptor/Ca2+ release channels (RyR) [7].
Contradictory, vitamin D can prevent lipogenesis in 
3T3-L1 cells [25–27]. Kong et al. showed that vitamin D 
significantly reduced the lipid-filling rate in adipose tis-
sue and moderated rats’ body weight. They suggested 
that vitamin D administration modified lipogenesis. They 
found that the protein levels of lipogenic factors, FAS, 
Stearoyl-CoA desaturase-1 (SCD1), and Acetyl-CoA car-
boxylase-1 (ACC1), were downregulated by vitamin D in 
adipose tissue of pregnant rats, the expression of SREBP-
1c and C/EBP-α did not significantly decrease in adipose 
tissue. Moreover, PPAR-γ was markedly upregulated by 
vitamin D in adipose tissue [28].
The exposure to BPA is associated to the activation 
of C/EBPα, LPL, and mTOR, involved in lipogenesis 
and secretion of adipokines. BPA increases the expres-
sion of IL-6 and INF-γ which activates proinflammatory 
pathway JNK/STAT3/NFκB [17]. On the other hand, C/
EBPβ induction happens early during the differentiation 
which involves mitotic clonal expansion and moderates 
the downstream upregulation of PPARγ and C/EBPα 
expression [28, 29]. In contrast to our results, Kong et al. 
presented that vitamin D had no effect on the expression 
level of C/EBPβ mRNA in the early stage of adipocyte 
differentiation. Consequently, they concluded that vita-
min D suppression of PPARγ and C/EBPα depends on C/
EBPβ expression. INSIG2 is recognized as an endoplas-
mic reticulum protein which binds to SREBP cleavage-
activating protein and inhibits SREBPs activation. The 
INSIG2 mRNA levels were considerably upregulated fol-
lowing treatment with vitamin D in adipose tissue. Our 
results also showed 0.1 nM vitamin D plus BPA overex-
pressed INSIG2 mRNA through differentiation [28].
Consistent to our findings, several evidence [29, 30] 
indicated that vitamin D antagonizes the transacting 
activity of PPARγ by competing for the limited amount of 
Fig. 4 Vitamin D plus BPA differentially regulates the mRNA expression of SREBP1c and INSIG2 during adipogenesis. mRNA expression of SREBP1c 
(a) and INSIG2 (b) in vitamin D groups during adipogenic differentiation. The relative qPCR values were corrected to GAPDH expression levels and 
normalized with respect to controls on each time. The mRNA levels are expressed as the fold increase relative to the control
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RXR by VDR. When vitamin D binds and activates VDR, 
it may sequester RXR from PPARγ in the early stage of 
adipogenesis. VDR overexpression happens around C/
EBPβ induction time. Thus, vitamin D will possibly 
inhibit adipocyte differentiation by preventing the reduc-
tion of VDR concentration in the late stages.
In contrast to our results which demonstrate an upreg-
ulation of adipogenic enzymes, FASN and LPL mRNA in 
the early stage accompanied by a decrease in the expres-
sion of FASN and LPL in the late stage of differentiation, 
Nimitphong et al. [23] showed that vitamin D increased 
LPL mRNA only during the later phase of adipogenesis 
in 3T3-L1.
The data indicated that BPA mediates as an obesogene 
by signaling through the activation of ER [23, 31–34].
Ohlstein et  al. [20] pointed out that BPA increased 
induction of ER and adipogenic genes C/EBPα, insu-
lin-like growth factor 1 (IFG1), PPARγ, and LPL dur-
ing differentiation of hASCs into adipocytes. While, 
the additional studies indicated that BPA exposure pro-
moted the expression of LPL [34, 35] and PPARγ [35, 
36]. Chamorro-Garcia et  al. [37] reported no effect in 
human BMSCs upon BPA treatment. Besides, Linehan 
et  al. indicated that by decreasing LPL mRNA expres-
sion, BPA prevents lipid accumulation in human stem 
cells. The expression level of C/EBPα, PPARγ, and FABP4 
were not significantly changed despite the upregulation 
of LPL through treatment with BPA, indicating that LPL 
can enhance the lipid accumulation independently of C/
EBPα, PPARγ, and FABP4 y[21].
Conclusions
One of the limitations of the present experiment is that 
lipid accumulation was not quantitatively measured dur-
ing the morphological evaluation of differentiated cells. 
However, more lipid vacuoles were observed in 10  nM 
vitamin D plus BPA group compared to control and 
0.1 nM vitamin D plus BPA groups.
To conclude, experimental studies identified the molec-
ular targets and signaling pathways which may play a role 
in the pathogenesis of obesity due to exposure to BPA 
through examining tissues such as the thyroid, pancreas, 
liver, and adipose. BPA, as an endocrine disruptor, may 
be involved in lipid metabolism, enhance, and accelerate 
adipogenesis.
The effects of vitamin D and VDR on adipogenesis 
are not exactly the same, and VDR acts as an enhancer 
of adipogenesis, the role of vitamin D is not specified. It 
is currently challenging to determine the role of vitamin 
D in adipogenesis. Further researches are guaranteed to 
clarify its effect on adipogenesis.
Table 1 Comparison of protein expression in vitamin D plus BPA 
groups vs. control
Expression levels of adipogenic markers [GLUT4 protein and FABP4 protein] 
were increased in vitamin D plus BPA (10 nM) group, compared to control and 
concentration of 0.1 nM vitamin D plus BPA. In addition, protein expression 
of VDR and ERβ in both concentrations of vitamin D plus BPA vs. control was 
significantly increased
FABP4 fatty acid binding proteins-4, GLUT4 glucose transporter-4, VDR vitamin D 
receptor, ERβ estrogen receptor beta
*Kruskal–Wallis test was used and Mean values were significantly different 
between the groups (P < 0.05)
a ng/mg total protein
Proteins Time Group Meana Standard 
deviation
Result
FABP4 Day 6 Control 0.27 0.03 X = 6.5
10 nM 
VitD + BPA
0.19 0.04 df = 2
0.1 nM 
VitD + BPA
0.04 0.008 P-value = 0.038*
Day 14 Control 0.32 0.02 X = 9. 04
10 nM 
VitD + BPA
0.32 0.05 df = 2
0.1 nM 
VitD + BPA
0.04 0.008 P-value = 0.01*
GLUT4 Day 6 Control 0.17 0.03 X = 9.75
10 nM 
VitD + BPA
0.12 0.02 df = 2
0.1 nM 
VitD + BPA
0.26 0.02 P-value = 0.007*
Day 14 Control 0.20 0.01 X = 7. 80
10 nM 
VitD + BPA
0.20 0.03 df = 2
0.1 nM 
VitD + BPA
0.29 0.04 P-value = 0.02*
VDR Day 6 Control 0.69 0.45 X = 5.02
10 nM 
VitD + BPA
0.49 0.05 df = 2
0.1 nM 
VitD + BPA
1.06 0.08 P-value = 0.08
Day 14 Control 0.80 0.05 X = 8. 05
10 nM 
VitD + BPA
0.82 0.05 df = 2
0.1 nM 
VitD + BPA
1.12 0.17 P-value = 0.017*
ERβ Day 6 Control 0.69 0.45 X = 5.02
10 nM 
VitD + BPA
0.79 0.18 df = 2
0.1 nM 
VitD + BPA
1.70 0.32 P-value = 0.08
Day 14 Control 0.80 0.05 X = 8. 05
10 nM 
VitD + BPA
1.32 0.71 df = 2
0.1 nM 
VitD + BPA
2.00 0.56 P-value = 0.017*
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dehydrogenase; GLUT-1: Glucose transporter-1; GLUT4: Glucose transporter-4; 
hADMSCs: Human adipose-derived mesenchymal stem cells; IBMX: 3-Isobutyl-
3-methylxanthine; IFG1: Insulin-like growth factor-1; INSIG2: Insulin- induced 
gene-2; IP3R: Inositol 1,4,5-trisphosphate receptor/Ca2+ release channels; 
LPL: Lipoprotein lipase; mRNA: Messenger ribonucleic acid; PBS: Phosphate-
buffered saline; PPARγ: Peroxisome proliferator-activated receptor-gamma; 
qPCR: Quantitative polymerase chain reaction; RXR: Retinoid X receptor; RyR: 
Ryanodine receptor/Ca2+ release channels; SCD1: Stearoyl-CoA desaturase-1; 
SD: Standard deviation; SREBP1c: Sterol regulatory element-binding protein-
1c; UCP2: Uncoupling protein-2; VDR: Vitamin D receptor; 1,25(OH)2D3: 
1,25-Dihydroxy-vitamin D3.
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